A number of other analysts also recently weighed in on GSK. Shore Capital reiterated a hold rating on shares of GlaxoSmithKline in a report on Thursday, August 22nd. Citigroup reiterated a neutral rating on shares of GlaxoSmithKline in a report on Tuesday, September 3rd. HSBC set a GBX 2,110 ($27.57) price target on GlaxoSmithKline and gave the stock a buy rating in a report on Tuesday, September 10th. Liberum Capital reiterated a hold rating on shares of GlaxoSmithKline in a report on Friday, August 23rd. Finally, Barclays reiterated an equal weight rating on shares of GlaxoSmithKline in a report on Friday. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and three have issued a buy rating to the stock. GlaxoSmithKline presently has an average rating of Hold and a consensus target price of GBX 1,701.79 ($22.24).
LON GSK opened at GBX 1,642.36 ($21.46) on Friday. The company has a market capitalization of $81.93 billion and a price-to-earnings ratio of 18.50. GlaxoSmithKline has a twelve month low of GBX 1,408.80 ($18.41) and a twelve month high of GBX 1,767 ($23.09). The stock has a fifty day simple moving average of GBX 1,680.89 and a 200 day simple moving average of GBX 1,591.61. The company has a quick ratio of 0.44, a current ratio of 0.71 and a debt-to-equity ratio of 1,127.74.
In other GlaxoSmithKline news, insider Vivienne Cox purchased 434 shares of the firm’s stock in a transaction on Wednesday, July 24th. The stock was purchased at an average cost of GBX 1,654 ($21.61) per share, for a total transaction of £7,178.36 ($9,379.80). Over the last quarter, insiders have acquired 457 shares of company stock valued at $755,906.
GlaxoSmithKline Company Profile
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.
See Also: What is the Quick Ratio?
Receive News & Ratings for GlaxoSmithKline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline and related companies with MarketBeat.com's FREE daily email newsletter.